Tumor Microenvironmental NRG1 Activation of HER3 As a Driver of Resistance to PI3K Pathway Inhibition in Prostate Cancer.

Tumor Microenvironmental NRG1 Activation of HER3 As a Driver of Resistance to PI3K Pathway Inhibition in Prostate Cancer. | AMiner